Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)

Completed · Phase 2

Conditions studied: Sexual Arousal Disorder

In brief

This 8 week at home study is designed to explore efficacy endpoints and evaluate the safety of intranasal Bremelanotide in women with Female Sexual Arousal Disorder. Efficacy will be assessed vs. a parallel placebo group.

Key facts

Study ID
NCT00425256
Run by
Palatin Technologies, Inc
Starts
2006-02-01
Expected to finish
2007-05-01
Last updated by the study team
2011-02-23

Who can join

Age: 21 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.